WAM
TTNP

Wealthspire Advisors (Maryland)’s Titan Pharmaceuticals TTNP Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2
Closed -$2K – 2599
2018
Q4 		$2K Hold
2
– – ﹤0.01% 2139
2018
Q3 		$2K Hold
2
– – ﹤0.01% 2196
2018
Q2 		$9K Sell
2
-1
-33% -$3.35K ﹤0.01% 1593
2018
Q1 		$12K Hold
3
– – ﹤0.01% 1502
2017
Q4 		$16K Hold
3
– – ﹤0.01% 1411
2017
Q3 		$20K Hold
3
– – ﹤0.01% 1303
2017
Q2 		$22K Hold
3
– – ﹤0.01% 1242
2017
Q1 		$39K Buy
+3
New +$42.2K 0.01% 870

Other funds holding TTNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WPA
Winning Points Advisors Boca Raton, Florida $74.8M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s TTNP Position: Q1 2019 in Review

Wealthspire Advisors (Maryland) sold out of Titan Pharmaceuticals (TTNP) in Q1 2019, closing a stake of 2 shares — an estimated $2K sold.

Wealthspire Advisors (Maryland) first reported a position in TTNP in Q1 2017 and held it in 8 quarters. The position peaked at $39K in Q1 2017. 15 funds tracked by Wall St. Rank hold TTNP as of Q1 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Titan Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 2 Titan Pharmaceuticals shares in Q1 2019, an estimated $2K.
  • Wealthspire Advisors (Maryland) first reported a position in Titan Pharmaceuticals in Q1 2017 and held it in 8 quarters.
  • Wealthspire Advisors (Maryland)'s Titan Pharmaceuticals position peaked at $39K in Q1 2017.
  • 15 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2019, filed 13 May 2019.